Legal Entity Identifier (LEI) No. 213800MDNBFVEQEN1G84
Triad Group Plc
("Triad" or "the Company")
Director Dealings
Triad Group Plc has been notified on 19 September 2024 of the following share purchases of, and transactions in, Ordinary Shares of the Company.
Dr John Rigg, Executive Chairman, has purchased a total of 125,000 Ordinary Shares at the price of 280 pence per share. Following the purchase, John Rigg holds 2,989,400 Ordinary Shares representing approximately 17.93% of the Company's issued share capital.
The information below, set out in accordance with the requirements of the UK Market Abuse Regulation, provides further detail on shares acquired.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Dr John Rigg | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Executive Chairman | ||||
| b) | Initial notification /Amendment | Initial | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Triad Group Plc | ||||
| b) | LEI | 213800MDNBFVEQEN1G84 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a)
| Description of the financial instrument, type of instrument
Identification code | Ordinary Shares of GBP £0.01 par value each
ISIN: GB0009035741 | ||||
| b) | Nature of the transaction | Purchase of shares | ||||
|
c)
|
Price(s) and volume(s) |
| ||||
| d)
| Aggregated information - Aggregated volume - Price |
125,000 £2.80 | ||||
| e) | Date of the transaction | 18 September 2024 | ||||
| f) | Place of the transaction | London Stock Exchange | ||||
For further information, please contact:
Triad Group Plc
James McDonald - Finance Director and Company Secretary
01908 278 450
Zeus Capital Ltd
Alexandra Campbell-Harris
Tel: 020 7614 5900
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.